Cyclophosphamide and Fludarabine Followed By Interleukin-2 Gene-Modified Tumor Infiltrating Lymphocytes in Treating Patients With Metastatic Melanoma

This study has been completed.

Study NCT00062036 Information provided by National Cancer Institute (NCI)

First Received: June 5, 2003 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)